Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

HHS issued a final rule updating transplant regulations to enable every U.S. transplant center to transplant kidneys and ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada ...

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...

If Democratic senators think leaving the door ajar for RFK Jr. will get them points for bipartisanship, I recommend they find ...

Memphis ranked second in the country for new HIV infections among metropolitan areas in the United States, according to the ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Abia State Agency for the Control of AIDS, ABSACA, has disclosed that 46,788 persons are currently undergoing treatment for ...